Biocure Technology Company Description

Biocure Technology Inc., together with its subsidiary, engages in developing and commercializing biopharmaceutical technologies for use in recombinant and ranibizumab.

The company is developing Interferons-β for the treatment of multiple sclerosis; Ranibizumab for age-related vision loss; and Filgrastim for chemotherapy effects treatments.

It also engages in the research and development of CAR T Cell therapy that identifies and destroys cancer cells.

Biocure Technology Inc. was founded in 2005 and is headquartered in Vancouver, Canada.

Biocure Technology Inc.

Country	Canada
Founded	2005
Industry	Biological Products, Except Diagnostic Substances
CEO	Yee Cheng

Contact Details

Address: 1055 West Hastings Street Vancouver, British Columbia V6E 2E9 Canada
Phone	604 609 7146
Website	biocuretech.com

Stock Details

Ticker Symbol	CURE.X
Exchange	Canadian Securities Exchange
Fiscal Year	January - December
Reporting Currency	CAD
SIC Code	2836

Key Executives

Name	Position
Yee Cheng	Chief Executive Officer
Konstantin Lichtenwald	Chief Financial Officer